WILLIAM THOMPSON: Open Payments
NPI 1023073699 · MONROE CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,058 in 114 payments from 30 companies in 2025. Trend: 2023 $2,325 · 2024 $1,978 · 2025 $2,058
Food & beverage: $2,019Education: $39
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $306 |
| ABBVIE INC. | 13 | $199 |
| PFIZER INC. | 11 | $167 |
| Amgen Inc. | 9 | $165 |
| AstraZeneca Pharmaceuticals LP | 6 | $159 |
| Merck Sharp & Dohme LLC | 8 | $144 |
| Axsome Therapeutics, Inc. | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $82 |
| Chiesi USA, Inc. | 2 | $68 |
Products named: Ozempic, VERQUVO, UBRELVY, Auvelity, OTEZLA, BREZTRI, REXULTI, Kerendia.
Industry payments across IN — which companies pay providers there.
